Invivox is the first worlwide plateform connecting doctors for a practical in situ medical training in 1 to 1 or in very small group.
Invivox has raised $7.7M in total funding. The most recent round was Series A. The last funding was announced in March 2022.
Invivox's investors include Bpifrance, Educapital, Wind, Isai, VentureOut.
Invivox is headquartered in Pessac, France.
Invivox is the first worlwide plateform connecting doctors for a practical in situ medical training in 1 to 1 or in very small group.
Invivox is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Invivox — Funding & Investors." VCBacked, March 23, 2022, https://www.vcbacked.co/company/invivox. Accessed September 29, 2026.
VCBacked. (2022). Invivox — Funding & Investors. Retrieved September 29, 2026, from https://www.vcbacked.co/company/invivox
{{cite web |title=Invivox — Funding & Investors |url=https://www.vcbacked.co/company/invivox |website=VCBacked |access-date=September 29, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated